OXIS International, Inc. Announces It Has Retained the Law Firm Quinn Emanuel Urquhart Oliver & Hedges, LLP to Protect and Defend All Patents Relating to Oxis' Unique Nutraceutical Compound, L-Ergothioneine (ERGO)
BEVERLY HILLS, Calif. – (Business Wire) OXIS INTERNATIONAL, INC. has announced the retention of Quinn Emanuel Urquhart Oliver & Hedges ("Quinn Emanuel") to enforce all patents related to the unique benefits of its potent antioxidant compound L-Ergothioneine ("ERGO").
Mr. Tony Cataldo, Chairman and Chief Executive Officer of Oxis, stated, "Oxis holds patents and patent applications on the benefits of ERGO as a significant combater of oxidative stress within the body. We have significant research that demonstrate ERGO's highly beneficial effects on the reduction in oxidative stress and we intend to pursue opportunities in the consumer market and have begun test marketing of products and through the recent financing have the financial resources to scale to full production launch in the near future."
"We intend to vigorously defend our patents against any potential infringer no matter how large or small they may be. Quinn Emanuel is the pre-eminent law firm in business litigation having won the most cases and the largest settlements of any law firm and ranked #1 in business litigation in the US. It has won over $10 billion in judgments and settlements, several of which have been for nine figures. We are proud to have them as part of the Oxis team and we are confident that potential infringers will think twice before doing so knowing that with Quinn Emanuel is on our side," Mr. Cataldo concluded.
Forward-Looking Statement - This press release contains forward-looking statements that involve numerous risks and uncertainties. Actual results, performance or achievements could differ materially from those anticipated in such forward-looking statements as a result of certain factors, including those set forth in the Company's filings with the Securities and Exchange Commission.